Sartorius (SDMHF.PK) said its first-quarter adjusted consolidated net profit after non-controlling interest, excluding non-cash amortization and valuation of hedging instruments, surged to 14.2 million euros or 0.83 euros per share from 10.6 million euros or 0.62 euros per share in the same quarter a year earlier.
Sales revenue for the three-month period climbed to 208.1 million euros from 172.1 million euros in the previous year.
Order intake for the quarter was 220 million euros versus 193.5 million euros a year ago.
Going ahead, based on the company's first-quarter performance, management confirms its guidance for sales and earnings growth for the current fiscal year. The company thus anticipates that full-year sales will grow by about 10% in constant currencies. Around five percentage points of this gain are forecast to be generated by the initial consolidation of the Biohit liquid handling business. Besides, management continues to project that operating EBITA will likewise increase by around 10%.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org